Correction to: Trials 21, 702 (2020)
https://doi.org/10.1186/s13063-020-04616-4
Following publication of the original article [1], we were notified that the authors would like to modify the article title to “Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial”, as it is conceptually and grammatically more accurate and reflective of the nature and topic.
Reference
Akram, et al. Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020;21:702. https://doi.org/10.1186/s13063-020-04616-4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Akram, J., Azhar, S., Shahzad, M. et al. Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial. Trials 21, 733 (2020). https://doi.org/10.1186/s13063-020-04697-1
Published:
DOI: https://doi.org/10.1186/s13063-020-04697-1